

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 5.68613163 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.37744726 |
| 3 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.30772011 |
| 4 | response to peptidoglycan (GO:0032494) | 5.12029444 |
| 5 | negative regulation of interleukin-12 production (GO:0032695) | 4.76638207 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.61145408 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.61145408 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.61145408 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.61145408 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.61145408 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.61145408 |
| 12 | negative regulation of cell killing (GO:0031342) | 4.45709435 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.45709435 |
| 14 | detection of external biotic stimulus (GO:0098581) | 4.38266939 |
| 15 | detection of other organism (GO:0098543) | 4.36783997 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.12206820 |
| 17 | neutrophil mediated immunity (GO:0002446) | 4.00620531 |
| 18 | detection of biotic stimulus (GO:0009595) | 3.98051089 |
| 19 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.92876316 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.92011204 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 3.83857638 |
| 22 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.70986244 |
| 23 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.69695635 |
| 24 | detection of bacterium (GO:0016045) | 3.61695259 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 3.60029411 |
| 26 | T-helper 1 type immune response (GO:0042088) | 3.45618627 |
| 27 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.44615724 |
| 28 | myeloid leukocyte mediated immunity (GO:0002444) | 3.41034448 |
| 29 | myeloid cell activation involved in immune response (GO:0002275) | 3.35681716 |
| 30 | neutrophil activation (GO:0042119) | 3.29337037 |
| 31 | response to laminar fluid shear stress (GO:0034616) | 3.28804726 |
| 32 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.24084718 |
| 33 | granulocyte activation (GO:0036230) | 3.23345272 |
| 34 | positive regulation of mast cell activation (GO:0033005) | 3.21243545 |
| 35 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.20974179 |
| 36 | negative regulation of T cell mediated immunity (GO:0002710) | 3.20397252 |
| 37 | respiratory burst (GO:0045730) | 3.13480611 |
| 38 | germinal center formation (GO:0002467) | 3.13072558 |
| 39 | positive regulation of p38MAPK cascade (GO:1900745) | 3.12432793 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.10932884 |
| 41 | regulation of mast cell degranulation (GO:0043304) | 3.09968790 |
| 42 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.08899666 |
| 43 | defense response to protozoan (GO:0042832) | 3.08103794 |
| 44 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.08083798 |
| 45 | positive regulation of interferon-alpha production (GO:0032727) | 3.07701537 |
| 46 | low-density lipoprotein particle clearance (GO:0034383) | 3.07538877 |
| 47 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.07307045 |
| 48 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.06392104 |
| 49 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.02218491 |
| 50 | regulation of cholesterol storage (GO:0010885) | 3.02190500 |
| 51 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.00679399 |
| 52 | regulation of mast cell activation (GO:0033003) | 2.99674717 |
| 53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.98017628 |
| 54 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.97234380 |
| 55 | leukocyte aggregation (GO:0070486) | 2.97069829 |
| 56 | microglial cell activation (GO:0001774) | 2.95723233 |
| 57 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.92981973 |
| 58 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.92873482 |
| 59 | negative regulation of interleukin-17 production (GO:0032700) | 2.92809514 |
| 60 | regulation of interferon-alpha production (GO:0032647) | 2.92523476 |
| 61 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.90547384 |
| 62 | germ cell migration (GO:0008354) | 2.88160276 |
| 63 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.87185374 |
| 64 | response to protozoan (GO:0001562) | 2.86460152 |
| 65 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.86440167 |
| 66 | regulation of macrophage cytokine production (GO:0010935) | 2.84737093 |
| 67 | positive regulation of macrophage cytokine production (GO:0060907) | 2.84619208 |
| 68 | B cell receptor signaling pathway (GO:0050853) | 2.81538020 |
| 69 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.80586332 |
| 70 | cellular response to ethanol (GO:0071361) | 2.80187155 |
| 71 | type I interferon signaling pathway (GO:0060337) | 2.80079537 |
| 72 | cellular response to type I interferon (GO:0071357) | 2.80079537 |
| 73 | response to muramyl dipeptide (GO:0032495) | 2.78138128 |
| 74 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.77362361 |
| 75 | cell adhesion mediated by integrin (GO:0033627) | 2.77340906 |
| 76 | response to type I interferon (GO:0034340) | 2.76689794 |
| 77 | regulation of leukocyte degranulation (GO:0043300) | 2.74342971 |
| 78 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.74184098 |
| 79 | positive regulation of mast cell degranulation (GO:0043306) | 2.74184098 |
| 80 | positive regulation of interferon-beta production (GO:0032728) | 2.73841304 |
| 81 | myeloid leukocyte activation (GO:0002274) | 2.73635396 |
| 82 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.72326276 |
| 83 | regulation of tolerance induction (GO:0002643) | 2.69554039 |
| 84 | negative regulation of lipid storage (GO:0010888) | 2.63808576 |
| 85 | positive regulation of interleukin-6 production (GO:0032755) | 2.63724097 |
| 86 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.62364987 |
| 87 | dendritic cell migration (GO:0036336) | 2.62169720 |
| 88 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.62161101 |
| 89 | positive regulation of B cell differentiation (GO:0045579) | 2.61194007 |
| 90 | neutrophil chemotaxis (GO:0030593) | 2.60989272 |
| 91 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.60190154 |
| 92 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.59007648 |
| 93 | positive regulation of type 2 immune response (GO:0002830) | 2.58892069 |
| 94 | positive regulation of leukocyte degranulation (GO:0043302) | 2.58443984 |
| 95 | pinocytosis (GO:0006907) | 2.58260001 |
| 96 | B cell mediated immunity (GO:0019724) | 2.57997421 |
| 97 | growth hormone receptor signaling pathway (GO:0060396) | 2.57437323 |
| 98 | plasma lipoprotein particle assembly (GO:0034377) | 2.56104255 |
| 99 | I-kappaB phosphorylation (GO:0007252) | 2.56017514 |
| 100 | protein carboxylation (GO:0018214) | 2.53671411 |
| 101 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.53671411 |
| 102 | phospholipid efflux (GO:0033700) | 2.52911584 |
| 103 | protein-lipid complex assembly (GO:0065005) | 2.49161562 |
| 104 | regulation of cholesterol homeostasis (GO:2000188) | 2.49066685 |
| 105 | embryonic process involved in female pregnancy (GO:0060136) | 2.48907254 |
| 106 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.43670705 |
| 107 | response to host immune response (GO:0052572) | 2.43670705 |
| 108 | regulation of integrin activation (GO:0033623) | 2.42606409 |
| 109 | plasma lipoprotein particle clearance (GO:0034381) | 2.42167279 |
| 110 | phospholipid homeostasis (GO:0055091) | 2.41839391 |
| 111 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.41756824 |
| 112 | protein localization to endosome (GO:0036010) | 2.41752923 |
| 113 | cytokine secretion (GO:0050663) | 2.41287901 |
| 114 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.40857311 |
| 115 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.40767057 |
| 116 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.39637713 |
| 117 | intestinal cholesterol absorption (GO:0030299) | 2.38308604 |
| 118 | macrophage activation (GO:0042116) | 2.38217024 |
| 119 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.36867257 |
| 120 | response to host (GO:0075136) | 2.36867257 |
| 121 | response to host defenses (GO:0052200) | 2.36867257 |
| 122 | positive regulation of blood coagulation (GO:0030194) | 2.36079053 |
| 123 | positive regulation of hemostasis (GO:1900048) | 2.36079053 |
| 124 | cholesterol efflux (GO:0033344) | 2.35011252 |
| 125 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.34808057 |
| 126 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.33999177 |
| 127 | response to lipoprotein particle (GO:0055094) | 2.33657624 |
| 128 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.30599321 |
| 129 | intestinal epithelial cell development (GO:0060576) | 2.28243978 |
| 130 | regulation of interferon-beta production (GO:0032648) | 2.27617668 |
| 131 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.26949019 |
| 132 | positive regulation of lipid storage (GO:0010884) | 2.26678855 |
| 133 | neutrophil activation involved in immune response (GO:0002283) | 2.26675419 |
| 134 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.26531476 |
| 135 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.24573184 |
| 136 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.22674509 |
| 137 | immunoglobulin mediated immune response (GO:0016064) | 2.20389393 |
| 138 | positive regulation of coagulation (GO:0050820) | 2.19830730 |
| 139 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.18160957 |
| 140 | hemidesmosome assembly (GO:0031581) | 2.17937321 |
| 141 | apoptotic cell clearance (GO:0043277) | 2.17383489 |
| 142 | response to arsenic-containing substance (GO:0046685) | 2.16943792 |
| 143 | serine family amino acid catabolic process (GO:0009071) | 2.16641484 |
| 144 | regulation of p38MAPK cascade (GO:1900744) | 2.16449317 |
| 145 | complement activation, alternative pathway (GO:0006957) | 2.15437270 |
| 146 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.14129658 |
| 147 | positive regulation of osteoblast proliferation (GO:0033690) | 2.13095342 |
| 148 | response to fluid shear stress (GO:0034405) | 2.12804949 |
| 149 | positive regulation of cholesterol efflux (GO:0010875) | 2.12710397 |
| 150 | embryonic placenta development (GO:0001892) | 2.10986359 |
| 151 | positive regulation of sterol transport (GO:0032373) | 2.10829709 |
| 152 | positive regulation of cholesterol transport (GO:0032376) | 2.10829709 |
| 153 | fibrinolysis (GO:0042730) | 2.10595118 |
| 154 | positive regulation of antigen processing and presentation (GO:0002579) | 2.09554018 |
| 155 | cellular response to growth hormone stimulus (GO:0071378) | 2.09032503 |
| 156 | cellular response to arsenic-containing substance (GO:0071243) | 2.07975702 |
| 157 | cellular extravasation (GO:0045123) | 2.07883278 |
| 158 | lipoprotein metabolic process (GO:0042157) | 2.07196317 |
| 159 | wound healing, spreading of epidermal cells (GO:0035313) | 2.06722477 |
| 160 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.06244050 |
| 161 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.05631412 |
| 162 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.03625709 |
| 163 | sterol homeostasis (GO:0055092) | 2.03610613 |
| 164 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.03453897 |
| 165 | cholesterol homeostasis (GO:0042632) | 2.01558237 |
| 166 | negative regulation of fibrinolysis (GO:0051918) | 2.01424291 |
| 167 | skin morphogenesis (GO:0043589) | 2.01005576 |
| 168 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.00480491 |
| 169 | positive regulation of histone deacetylation (GO:0031065) | 1.99208305 |
| 170 | mannose metabolic process (GO:0006013) | 1.98981927 |
| 171 | urea cycle (GO:0000050) | 1.98921240 |
| 172 | urea metabolic process (GO:0019627) | 1.98921240 |
| 173 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 1.98912807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.25115899 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.19954129 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.73072781 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.48438969 |
| 5 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.98679343 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.96604664 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.94128669 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76426821 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.70853095 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.60756700 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.60223894 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.54198798 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.52725301 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.48288335 |
| 15 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.44487208 |
| 16 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.44205181 |
| 17 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.43520681 |
| 18 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43140163 |
| 19 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.38973410 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.28968497 |
| 21 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.12196782 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.09530776 |
| 23 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08182152 |
| 24 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.02671037 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.95762335 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.92715275 |
| 27 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.85286484 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84433559 |
| 29 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.82059857 |
| 30 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.81913338 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76948716 |
| 32 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.76673667 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74873036 |
| 34 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.72747927 |
| 35 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.68934087 |
| 36 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.68101941 |
| 37 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.67149930 |
| 38 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.64601071 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62621991 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.62499024 |
| 41 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.61098839 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.60547037 |
| 43 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60339613 |
| 44 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.59240036 |
| 45 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.56249280 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.52278161 |
| 47 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.52067875 |
| 48 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50397629 |
| 49 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.50022735 |
| 50 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48791256 |
| 51 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.47171348 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46815309 |
| 53 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43670529 |
| 54 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.42892989 |
| 55 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.42892989 |
| 56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42116661 |
| 57 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.41103949 |
| 58 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39724963 |
| 59 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39244629 |
| 60 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.39075681 |
| 61 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.38981760 |
| 62 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.35826710 |
| 63 | MAF_26560356_Chip-Seq_TH1_Human | 1.35759791 |
| 64 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35447559 |
| 65 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.34703396 |
| 66 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.34703396 |
| 67 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.34703396 |
| 68 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.33532708 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.32532449 |
| 70 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31460167 |
| 71 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.27829400 |
| 72 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27374647 |
| 73 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.26658762 |
| 74 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25899971 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24398407 |
| 76 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24169313 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23848632 |
| 78 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23724390 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23125204 |
| 80 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.22315649 |
| 81 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22086366 |
| 82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21415715 |
| 83 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.21178174 |
| 84 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20290842 |
| 85 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.19949580 |
| 86 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19798632 |
| 87 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.19609582 |
| 88 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.19415917 |
| 89 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18125095 |
| 90 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.17569807 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.17410496 |
| 92 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.17346817 |
| 93 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15053913 |
| 94 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.14916900 |
| 95 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.14479521 |
| 96 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14285233 |
| 97 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12594753 |
| 98 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11587457 |
| 99 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10588742 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.10154709 |
| 101 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09686158 |
| 102 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.09366473 |
| 103 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.08888088 |
| 104 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07677270 |
| 105 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07369958 |
| 106 | * MYC_22102868_ChIP-Seq_BL_Human | 1.07257906 |
| 107 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06123633 |
| 108 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05863509 |
| 109 | MYB_26560356_Chip-Seq_TH1_Human | 1.05751914 |
| 110 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.05224893 |
| 111 | MYB_26560356_Chip-Seq_TH2_Human | 1.04996158 |
| 112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04772925 |
| 113 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.04644767 |
| 114 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.04528391 |
| 115 | UTX_26944678_Chip-Seq_JUKART_Human | 1.04206597 |
| 116 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04201160 |
| 117 | CJUN_26792858_Chip-Seq_BT549_Human | 1.04028707 |
| 118 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.03982458 |
| 119 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01561780 |
| 120 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01410057 |
| 121 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.01333183 |
| 122 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.00136695 |
| 123 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.00076038 |
| 124 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99941848 |
| 125 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.99366873 |
| 126 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.98936114 |
| 127 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.91101337 |
| 128 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.90393749 |
| 129 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88007136 |
| 130 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87820352 |
| 131 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85181641 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82064574 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82064574 |
| 134 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.82064488 |
| 135 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.78909062 |
| 136 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78040049 |
| 137 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.77458721 |
| 138 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.76580241 |
| 139 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.76203221 |
| 140 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.74027271 |
| 141 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74014789 |
| 142 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73132719 |
| 143 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.72372959 |
| 144 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72172539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 2.85105856 |
| 2 | MP0009840_abnormal_foam_cell | 2.64698778 |
| 3 | MP0003303_peritoneal_inflammation | 2.63896984 |
| 4 | MP0000569_abnormal_digit_pigmentation | 2.52630107 |
| 5 | MP0005671_abnormal_response_to | 2.16129107 |
| 6 | MP0005360_urolithiasis | 2.13664304 |
| 7 | MP0008260_abnormal_autophagy | 2.11407471 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.10563996 |
| 9 | MP0010352_gastrointestinal_tract_polyps | 2.08773474 |
| 10 | MP0002254_reproductive_system_inflammat | 2.06929481 |
| 11 | MP0009764_decreased_sensitivity_to | 1.99114956 |
| 12 | MP0003436_decreased_susceptibility_to | 1.98523773 |
| 13 | MP0003172_abnormal_lysosome_physiology | 1.92993799 |
| 14 | MP0009278_abnormal_bone_marrow | 1.86115278 |
| 15 | MP0005076_abnormal_cell_differentiation | 1.84253551 |
| 16 | MP0003300_gastrointestinal_ulcer | 1.78602693 |
| 17 | MP0005058_abnormal_lysosome_morphology | 1.76021101 |
| 18 | MP0006082_CNS_inflammation | 1.70270074 |
| 19 | MP0004947_skin_inflammation | 1.68737772 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 1.67013425 |
| 21 | MP0003566_abnormal_cell_adhesion | 1.63075141 |
| 22 | MP0003453_abnormal_keratinocyte_physiol | 1.62547035 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.58250748 |
| 24 | MP0005085_abnormal_gallbladder_physiolo | 1.56467034 |
| 25 | MP0002398_abnormal_bone_marrow | 1.54578739 |
| 26 | MP0000716_abnormal_immune_system | 1.53405977 |
| 27 | MP0005451_abnormal_body_composition | 1.52452480 |
| 28 | MP0004185_abnormal_adipocyte_glucose | 1.52098617 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.51270788 |
| 30 | MP0004883_abnormal_blood_vessel | 1.50666004 |
| 31 | MP0005365_abnormal_bile_salt | 1.47369616 |
| 32 | MP0002419_abnormal_innate_immunity | 1.45664881 |
| 33 | MP0008438_abnormal_cutaneous_collagen | 1.45248418 |
| 34 | MP0000858_altered_metastatic_potential | 1.41730581 |
| 35 | MP0008057_abnormal_DNA_replication | 1.41459535 |
| 36 | MP0003448_altered_tumor_morphology | 1.40679144 |
| 37 | MP0005310_abnormal_salivary_gland | 1.38072596 |
| 38 | MP0009053_abnormal_anal_canal | 1.38043982 |
| 39 | MP0004510_myositis | 1.35658137 |
| 40 | MP0003690_abnormal_glial_cell | 1.34548992 |
| 41 | MP0010234_abnormal_vibrissa_follicle | 1.34346969 |
| 42 | MP0002796_impaired_skin_barrier | 1.33985157 |
| 43 | MP0002006_tumorigenesis | 1.33319849 |
| 44 | MP0003075_altered_response_to | 1.32856147 |
| 45 | MP0008004_abnormal_stomach_pH | 1.31098819 |
| 46 | * MP0005164_abnormal_response_to | 1.30619561 |
| 47 | MP0003724_increased_susceptibility_to | 1.29339211 |
| 48 | MP0002332_abnormal_exercise_endurance | 1.28814437 |
| 49 | MP0002452_abnormal_antigen_presenting | 1.28633203 |
| 50 | MP0000689_abnormal_spleen_morphology | 1.28591326 |
| 51 | MP0002722_abnormal_immune_system | 1.28534672 |
| 52 | MP0003252_abnormal_bile_duct | 1.27653046 |
| 53 | MP0000685_abnormal_immune_system | 1.26222342 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.25998426 |
| 55 | MP0001800_abnormal_humoral_immune | 1.25376099 |
| 56 | MP0010307_abnormal_tumor_latency | 1.23325343 |
| 57 | MP0005023_abnormal_wound_healing | 1.22829305 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.21718041 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.21283840 |
| 60 | MP0005000_abnormal_immune_tolerance | 1.20253516 |
| 61 | MP0000609_abnormal_liver_physiology | 1.20057452 |
| 62 | MP0002060_abnormal_skin_morphology | 1.19394975 |
| 63 | MP0002429_abnormal_blood_cell | 1.19344741 |
| 64 | MP0000733_abnormal_muscle_development | 1.19037038 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 1.18959279 |
| 66 | MP0002009_preneoplasia | 1.17578636 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.16605097 |
| 68 | MP0010678_abnormal_skin_adnexa | 1.16226534 |
| 69 | MP0000383_abnormal_hair_follicle | 1.15083554 |
| 70 | MP0000604_amyloidosis | 1.13576543 |
| 71 | MP0001216_abnormal_epidermal_layer | 1.12829112 |
| 72 | MP0005166_decreased_susceptibility_to | 1.12483679 |
| 73 | MP0005025_abnormal_response_to | 1.09753021 |
| 74 | MP0001851_eye_inflammation | 1.09548556 |
| 75 | MP0001790_abnormal_immune_system | 1.09275333 |
| 76 | MP0005387_immune_system_phenotype | 1.09275333 |
| 77 | MP0002166_altered_tumor_susceptibility | 1.07729281 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 1.06700606 |
| 79 | MP0001545_abnormal_hematopoietic_system | 1.06700606 |
| 80 | MP0001915_intracranial_hemorrhage | 1.06039403 |
| 81 | MP0002132_abnormal_respiratory_system | 1.05735862 |
| 82 | MP0005275_abnormal_skin_tensile | 1.05700858 |
| 83 | MP0002723_abnormal_immune_serum | 1.04808743 |
| 84 | MP0010155_abnormal_intestine_physiology | 1.04547123 |
| 85 | MP0002405_respiratory_system_inflammati | 1.03184853 |
| 86 | MP0003091_abnormal_cell_migration | 1.03127084 |
| 87 | MP0002877_abnormal_melanocyte_morpholog | 1.02596469 |
| 88 | * MP0000767_abnormal_smooth_muscle | 1.00843675 |
| 89 | MP0002396_abnormal_hematopoietic_system | 1.00459970 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 1.00179435 |
| 91 | MP0000015_abnormal_ear_pigmentation | 1.00077440 |
| 92 | MP0005083_abnormal_biliary_tract | 0.98625396 |
| 93 | MP0003828_pulmonary_edema | 0.97964083 |
| 94 | MP0010329_abnormal_lipoprotein_level | 0.97815974 |
| 95 | MP0002148_abnormal_hypersensitivity_rea | 0.97137916 |
| 96 | MP0001879_abnormal_lymphatic_vessel | 0.95004572 |
| 97 | MP0005367_renal/urinary_system_phenotyp | 0.94075398 |
| 98 | MP0000516_abnormal_urinary_system | 0.94075398 |
| 99 | MP0001666_abnormal_nutrient_absorption | 0.93278477 |
| 100 | MP0001845_abnormal_inflammatory_respons | 0.92436893 |
| 101 | MP0009785_altered_susceptibility_to | 0.92269904 |
| 102 | MP0001819_abnormal_immune_cell | 0.90250128 |
| 103 | MP0006054_spinal_hemorrhage | 0.90062190 |
| 104 | MP0000703_abnormal_thymus_morphology | 0.89978706 |
| 105 | MP0002420_abnormal_adaptive_immunity | 0.88759846 |
| 106 | MP0002998_abnormal_bone_remodeling | 0.88661769 |
| 107 | MP0002098_abnormal_vibrissa_morphology | 0.88310778 |
| 108 | MP0010368_abnormal_lymphatic_system | 0.88119988 |
| 109 | MP0009333_abnormal_splenocyte_physiolog | 0.87150313 |
| 110 | MP0009763_increased_sensitivity_to | 0.87108753 |
| 111 | MP0003567_abnormal_fetal_cardiomyocyte | 0.86709305 |
| 112 | MP0003941_abnormal_skin_development | 0.85333820 |
| 113 | MP0001243_abnormal_dermal_layer | 0.84718073 |
| 114 | MP0008469_abnormal_protein_level | 0.84524596 |
| 115 | MP0005408_hypopigmentation | 0.83168259 |
| 116 | MP0005501_abnormal_skin_physiology | 0.82146740 |
| 117 | MP0003950_abnormal_plasma_membrane | 0.82039786 |
| 118 | MP0000598_abnormal_liver_morphology | 0.82004353 |
| 119 | MP0000377_abnormal_hair_follicle | 0.81963879 |
| 120 | MP0004808_abnormal_hematopoietic_stem | 0.81898030 |
| 121 | MP0005666_abnormal_adipose_tissue | 0.80806095 |
| 122 | MP0000343_altered_response_to | 0.80538365 |
| 123 | MP0002086_abnormal_extraembryonic_tissu | 0.80341167 |
| 124 | MP0008875_abnormal_xenobiotic_pharmacok | 0.80050094 |
| 125 | MP0004272_abnormal_basement_membrane | 0.80011308 |
| 126 | MP0000371_diluted_coat_color | 0.79989761 |
| 127 | MP0004381_abnormal_hair_follicle | 0.79740959 |
| 128 | * MP0003221_abnormal_cardiomyocyte_apopto | 0.79488914 |
| 129 | MP0001849_ear_inflammation | 0.79281184 |
| 130 | MP0000249_abnormal_blood_vessel | 0.78487270 |
| 131 | MP0003866_abnormal_defecation | 0.78399303 |
| 132 | MP0003045_fibrosis | 0.77267900 |
| 133 | MP0009931_abnormal_skin_appearance | 0.77040097 |
| 134 | MP0005390_skeleton_phenotype | 0.76903813 |
| 135 | MP0005167_abnormal_blood-brain_barrier | 0.76727603 |
| 136 | MP0004782_abnormal_surfactant_physiolog | 0.76516209 |
| 137 | MP0001853_heart_inflammation | 0.76287402 |
| 138 | MP0009765_abnormal_xenobiotic_induced | 0.75480468 |
| 139 | MP0004484_altered_response_of | 0.72817410 |
| 140 | MP0003795_abnormal_bone_structure | 0.64645613 |
| 141 | MP0002277_abnormal_respiratory_mucosa | 0.64255255 |
| 142 | MP0005174_abnormal_tail_pigmentation | 0.61410729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Optic neuritis (HP:0100653) | 5.21583554 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 5.21583554 |
| 3 | Stomatitis (HP:0010280) | 3.98655154 |
| 4 | Myocardial infarction (HP:0001658) | 3.91726385 |
| 5 | Keratoconjunctivitis sicca (HP:0001097) | 3.89646044 |
| 6 | Thick nail (HP:0001805) | 3.88513857 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 3.83325833 |
| 8 | Gastrointestinal infarctions (HP:0005244) | 3.67926009 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 3.62600964 |
| 10 | Keratoconjunctivitis (HP:0001096) | 3.54719466 |
| 11 | Eczematoid dermatitis (HP:0000976) | 3.54349962 |
| 12 | T lymphocytopenia (HP:0005403) | 3.51835765 |
| 13 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.47730400 |
| 14 | Abnormality of T cell number (HP:0011839) | 3.30456425 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.20491164 |
| 16 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.11972088 |
| 17 | Osteolytic defects of the hand bones (HP:0009699) | 3.11972088 |
| 18 | Hematochezia (HP:0002573) | 3.10751224 |
| 19 | Vasculitis (HP:0002633) | 3.07559219 |
| 20 | Complement deficiency (HP:0004431) | 3.05439668 |
| 21 | Glomerulonephritis (HP:0000099) | 3.01957689 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 3.00149511 |
| 23 | Recurrent abscess formation (HP:0002722) | 2.92841996 |
| 24 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.91284343 |
| 25 | Xanthomatosis (HP:0000991) | 2.90337115 |
| 26 | Hemoptysis (HP:0002105) | 2.89922598 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 2.87147102 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.87147102 |
| 29 | Pulmonary infiltrates (HP:0002113) | 2.87090357 |
| 30 | Increased cerebral lipofuscin (HP:0011813) | 2.86078887 |
| 31 | Obstructive lung disease (HP:0006536) | 2.85512844 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 2.85512844 |
| 33 | Urticaria (HP:0001025) | 2.84974853 |
| 34 | Abnormality of complement system (HP:0005339) | 2.83188961 |
| 35 | Meningitis (HP:0001287) | 2.80931841 |
| 36 | Pustule (HP:0200039) | 2.78102774 |
| 37 | Premature rupture of membranes (HP:0001788) | 2.75055332 |
| 38 | Disinhibition (HP:0000734) | 2.72572177 |
| 39 | Deep venous thrombosis (HP:0002625) | 2.68858173 |
| 40 | Encephalitis (HP:0002383) | 2.67433909 |
| 41 | Gangrene (HP:0100758) | 2.66925489 |
| 42 | Chest pain (HP:0100749) | 2.62358527 |
| 43 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.57799097 |
| 44 | Hypoalphalipoproteinemia (HP:0003233) | 2.51572587 |
| 45 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.48383176 |
| 46 | Cerebral aneurysm (HP:0004944) | 2.43694288 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.43046715 |
| 48 | Esophageal varix (HP:0002040) | 2.40703319 |
| 49 | Episodic fever (HP:0001954) | 2.37975382 |
| 50 | Papillary thyroid carcinoma (HP:0002895) | 2.37545381 |
| 51 | Epistaxis (HP:0000421) | 2.36461464 |
| 52 | Prolonged bleeding time (HP:0003010) | 2.32099289 |
| 53 | Peritonitis (HP:0002586) | 2.31005755 |
| 54 | Loss of speech (HP:0002371) | 2.30102359 |
| 55 | Osteomyelitis (HP:0002754) | 2.29676293 |
| 56 | Pulmonary embolism (HP:0002204) | 2.27520965 |
| 57 | Anorexia (HP:0002039) | 2.25143307 |
| 58 | Abnormality of macrophages (HP:0004311) | 2.23561730 |
| 59 | Polycythemia (HP:0001901) | 2.23215003 |
| 60 | Abnormality of the common coagulation pathway (HP:0010990) | 2.23120290 |
| 61 | Nephritis (HP:0000123) | 2.21253602 |
| 62 | Alopecia of scalp (HP:0002293) | 2.19382357 |
| 63 | Autoimmune hemolytic anemia (HP:0001890) | 2.17149888 |
| 64 | Abnormality of the peritoneum (HP:0002585) | 2.14680879 |
| 65 | Viral hepatitis (HP:0006562) | 2.12756878 |
| 66 | Hypolipoproteinemia (HP:0010981) | 2.12712278 |
| 67 | Intrahepatic cholestasis (HP:0001406) | 2.11417331 |
| 68 | Joint hemorrhage (HP:0005261) | 2.10199216 |
| 69 | Mitral valve prolapse (HP:0001634) | 2.09846534 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.09597745 |
| 71 | Slow saccadic eye movements (HP:0000514) | 2.09431845 |
| 72 | Conjunctival telangiectasia (HP:0000524) | 2.08097020 |
| 73 | Abnormality of T cells (HP:0002843) | 2.07724045 |
| 74 | Fatigue (HP:0012378) | 2.07432707 |
| 75 | Gingivitis (HP:0000230) | 2.06266869 |
| 76 | Polyneuropathy (HP:0001271) | 2.06092269 |
| 77 | Glomerulopathy (HP:0100820) | 2.05870655 |
| 78 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.05371747 |
| 79 | Increased connective tissue (HP:0009025) | 2.04928717 |
| 80 | Amaurosis fugax (HP:0100576) | 2.01255181 |
| 81 | Abnormality of the endocardium (HP:0004306) | 2.00667844 |
| 82 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.00371237 |
| 83 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.00292359 |
| 84 | Colitis (HP:0002583) | 1.99546936 |
| 85 | Abnormality of the pleura (HP:0002103) | 1.98970365 |
| 86 | Keratitis (HP:0000491) | 1.98090704 |
| 87 | Vertigo (HP:0002321) | 1.97687681 |
| 88 | Orchitis (HP:0100796) | 1.95519416 |
| 89 | Thoracolumbar scoliosis (HP:0002944) | 1.95317007 |
| 90 | Tetraparesis (HP:0002273) | 1.91413440 |
| 91 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.90313491 |
| 92 | Gastrointestinal inflammation (HP:0004386) | 1.87720271 |
| 93 | Urethral obstruction (HP:0000796) | 1.87639268 |
| 94 | Autoimmune thrombocytopenia (HP:0001973) | 1.87425849 |
| 95 | Spondylolisthesis (HP:0003302) | 1.86885011 |
| 96 | Vacuolated lymphocytes (HP:0001922) | 1.86743862 |
| 97 | Hypercholesterolemia (HP:0003124) | 1.86145658 |
| 98 | Abnormality of lateral ventricle (HP:0030047) | 1.86090401 |
| 99 | Peripheral demyelination (HP:0011096) | 1.85526787 |
| 100 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.85514218 |
| 101 | Dysostosis multiplex (HP:0000943) | 1.84790175 |
| 102 | Thrombophlebitis (HP:0004418) | 1.84624853 |
| 103 | Gingival bleeding (HP:0000225) | 1.82799279 |
| 104 | Granulocytopenia (HP:0001913) | 1.82363569 |
| 105 | Sepsis (HP:0100806) | 1.81825024 |
| 106 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.81714656 |
| 107 | Abnormal platelet function (HP:0011869) | 1.81628982 |
| 108 | Impaired platelet aggregation (HP:0003540) | 1.81628982 |
| 109 | Epidermoid cyst (HP:0200040) | 1.81430599 |
| 110 | Recurrent fungal infections (HP:0002841) | 1.81074623 |
| 111 | Myositis (HP:0100614) | 1.80692306 |
| 112 | Subacute progressive viral hepatitis (HP:0006572) | 1.80532630 |
| 113 | Leukocytosis (HP:0001974) | 1.79189865 |
| 114 | Disproportionate tall stature (HP:0001519) | 1.78580645 |
| 115 | Malnutrition (HP:0004395) | 1.78547039 |
| 116 | Persistence of primary teeth (HP:0006335) | 1.76579476 |
| 117 | Hypobetalipoproteinemia (HP:0003563) | 1.74605113 |
| 118 | Recurrent skin infections (HP:0001581) | 1.72711253 |
| 119 | Periodontitis (HP:0000704) | 1.72577941 |
| 120 | Axonal loss (HP:0003447) | 1.72221720 |
| 121 | Hyperglycemia (HP:0003074) | 1.72129880 |
| 122 | Recurrent pneumonia (HP:0006532) | 1.71081279 |
| 123 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.70821167 |
| 124 | Acne (HP:0001061) | 1.70763839 |
| 125 | Aortic aneurysm (HP:0004942) | 1.70432643 |
| 126 | Interstitial pulmonary disease (HP:0006530) | 1.69966856 |
| 127 | Abnormality of the pericardium (HP:0001697) | 1.69586982 |
| 128 | Shallow orbits (HP:0000586) | 1.69520485 |
| 129 | Hydroxyprolinuria (HP:0003080) | 1.68172332 |
| 130 | Abnormality of proline metabolism (HP:0010907) | 1.68172332 |
| 131 | Increased mean platelet volume (HP:0011877) | 1.67390803 |
| 132 | Stomach cancer (HP:0012126) | 1.66511067 |
| 133 | Protrusio acetabuli (HP:0003179) | 1.65221105 |
| 134 | Prostate neoplasm (HP:0100787) | 1.63770221 |
| 135 | Short nail (HP:0001799) | 1.63193942 |
| 136 | Cellulitis (HP:0100658) | 1.63182239 |
| 137 | Syringomyelia (HP:0003396) | 1.62748984 |
| 138 | Spinal cord lesions (HP:0100561) | 1.62748984 |
| 139 | Increased IgE level (HP:0003212) | 1.62553564 |
| 140 | Abnormal platelet volume (HP:0011876) | 1.61815381 |
| 141 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.61237189 |
| 142 | Submucous cleft hard palate (HP:0000176) | 1.60125285 |
| 143 | Arterial tortuosity (HP:0005116) | 1.59203707 |
| 144 | Amyloidosis (HP:0011034) | 1.56521179 |
| 145 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.56193643 |
| 146 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.56193643 |
| 147 | Abnormality of glycolipid metabolism (HP:0010969) | 1.56193643 |
| 148 | Hyperlipoproteinemia (HP:0010980) | 1.56085715 |
| 149 | Increased density of long bones (HP:0006392) | 1.55771805 |
| 150 | Muscle fiber splitting (HP:0003555) | 1.54590788 |
| 151 | Arterial thrombosis (HP:0004420) | 1.53490684 |
| 152 | Eosinophilia (HP:0001880) | 1.52679775 |
| 153 | Congenital, generalized hypertrichosis (HP:0004540) | 1.52466704 |
| 154 | Prolonged partial thromboplastin time (HP:0003645) | 1.51639930 |
| 155 | Recurrent viral infections (HP:0004429) | 1.51144034 |
| 156 | Difficulty climbing stairs (HP:0003551) | 1.50077539 |
| 157 | Skin nodule (HP:0200036) | 1.50069963 |
| 158 | Cupped ribs (HP:0000887) | 1.49866733 |
| 159 | Hepatocellular carcinoma (HP:0001402) | 1.49759943 |
| 160 | Coarse hair (HP:0002208) | 1.48732244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.77591019 |
| 2 | TGFBR2 | 3.03441278 |
| 3 | EPHB1 | 2.45921696 |
| 4 | PRPF4B | 2.44513965 |
| 5 | LATS1 | 2.41173972 |
| 6 | FGFR4 | 2.27813371 |
| 7 | TYK2 | 2.18554934 |
| 8 | EPHA3 | 2.12648693 |
| 9 | STK10 | 2.08453034 |
| 10 | MAP3K10 | 2.04827575 |
| 11 | ERN1 | 2.01027944 |
| 12 | MAP3K14 | 1.98355924 |
| 13 | TRIB3 | 1.97553504 |
| 14 | TBK1 | 1.93862772 |
| 15 | MAP3K3 | 1.87222375 |
| 16 | NUAK1 | 1.83227712 |
| 17 | STK3 | 1.78121856 |
| 18 | IKBKB | 1.76767342 |
| 19 | CDK12 | 1.75146826 |
| 20 | PTK6 | 1.74779766 |
| 21 | MATK | 1.69902918 |
| 22 | IRAK2 | 1.67000266 |
| 23 | MAP3K13 | 1.66236738 |
| 24 | CDK6 | 1.64430609 |
| 25 | BLK | 1.58483473 |
| 26 | TAOK3 | 1.54083779 |
| 27 | PIK3CG | 1.52080655 |
| 28 | MAP3K2 | 1.51981130 |
| 29 | KSR2 | 1.51378998 |
| 30 | TXK | 1.51241135 |
| 31 | CHUK | 1.41876508 |
| 32 | RIPK1 | 1.40774199 |
| 33 | MST1R | 1.40340776 |
| 34 | MAP3K1 | 1.40153317 |
| 35 | SYK | 1.38161801 |
| 36 | FES | 1.38152643 |
| 37 | YES1 | 1.37680077 |
| 38 | TTN | 1.37214108 |
| 39 | PIM1 | 1.36730913 |
| 40 | MAP2K3 | 1.31495785 |
| 41 | IRAK3 | 1.29291028 |
| 42 | BTK | 1.28725831 |
| 43 | CSK | 1.27816760 |
| 44 | GSK3A | 1.24116044 |
| 45 | FGFR3 | 1.20869172 |
| 46 | LYN | 1.13332238 |
| 47 | EPHA2 | 1.11784165 |
| 48 | PKN2 | 1.11742443 |
| 49 | MAP4K1 | 1.10750349 |
| 50 | CAMK1D | 1.09552307 |
| 51 | DMPK | 1.09215494 |
| 52 | EPHB2 | 1.08577295 |
| 53 | PDGFRB | 1.08072504 |
| 54 | STK4 | 1.07514624 |
| 55 | NEK9 | 1.07444816 |
| 56 | ACVR1B | 1.05996649 |
| 57 | IKBKE | 1.04413386 |
| 58 | LRRK2 | 1.04137472 |
| 59 | PAK4 | 1.04002748 |
| 60 | MAP3K6 | 1.02471431 |
| 61 | BMX | 0.99484024 |
| 62 | ITK | 0.98182882 |
| 63 | KSR1 | 0.96913179 |
| 64 | WNK1 | 0.96698535 |
| 65 | MOS | 0.96224559 |
| 66 | TEC | 0.95536944 |
| 67 | JAK1 | 0.94988713 |
| 68 | RPS6KA4 | 0.94524433 |
| 69 | CSF1R | 0.93769726 |
| 70 | EEF2K | 0.93091549 |
| 71 | MTOR | 0.91123088 |
| 72 | MET | 0.90806509 |
| 73 | SGK2 | 0.90691561 |
| 74 | RAF1 | 0.90039536 |
| 75 | SGK3 | 0.89829622 |
| 76 | TAOK2 | 0.88436821 |
| 77 | IRAK4 | 0.87746902 |
| 78 | PIM2 | 0.86050742 |
| 79 | JAK2 | 0.85371344 |
| 80 | MELK | 0.84950898 |
| 81 | NEK2 | 0.83135699 |
| 82 | TGFBR1 | 0.82628935 |
| 83 | DYRK1B | 0.81543267 |
| 84 | HCK | 0.80503779 |
| 85 | FGR | 0.80002872 |
| 86 | MST4 | 0.79027974 |
| 87 | ERBB4 | 0.78841541 |
| 88 | PAK2 | 0.77668199 |
| 89 | PRKAA2 | 0.76711963 |
| 90 | ZAP70 | 0.75523969 |
| 91 | CLK1 | 0.74982108 |
| 92 | BRD4 | 0.74208398 |
| 93 | ALK | 0.72762256 |
| 94 | KIT | 0.72641521 |
| 95 | GRK6 | 0.71636394 |
| 96 | CDK9 | 0.70308173 |
| 97 | MAP2K2 | 0.70156985 |
| 98 | MARK2 | 0.68725872 |
| 99 | TRPM7 | 0.67003558 |
| 100 | PDK1 | 0.66348834 |
| 101 | IRAK1 | 0.65974180 |
| 102 | MAPK15 | 0.65578981 |
| 103 | MAP3K8 | 0.63620676 |
| 104 | LATS2 | 0.62831932 |
| 105 | PDGFRA | 0.62823707 |
| 106 | MAP3K5 | 0.62798611 |
| 107 | AKT3 | 0.61638099 |
| 108 | DYRK3 | 0.60109230 |
| 109 | GRK7 | 0.59952431 |
| 110 | DDR2 | 0.59348375 |
| 111 | CDC42BPA | 0.58917299 |
| 112 | NEK6 | 0.58223268 |
| 113 | MAPK7 | 0.58111763 |
| 114 | ABL1 | 0.57628713 |
| 115 | EGFR | 0.56804284 |
| 116 | FRK | 0.56329492 |
| 117 | MKNK2 | 0.54247537 |
| 118 | MARK3 | 0.53850864 |
| 119 | FGFR2 | 0.53705114 |
| 120 | SIK1 | 0.53476939 |
| 121 | CDK4 | 0.52622551 |
| 122 | PDPK1 | 0.51764505 |
| 123 | JAK3 | 0.50642971 |
| 124 | BMPR2 | 0.48876850 |
| 125 | EIF2AK2 | 0.48459801 |
| 126 | MAP3K11 | 0.47994351 |
| 127 | PTK2 | 0.47172358 |
| 128 | NLK | 0.46736697 |
| 129 | RET | 0.45644535 |
| 130 | MAPKAPK2 | 0.45350672 |
| 131 | MAP2K4 | 0.44520641 |
| 132 | STK24 | 0.44494948 |
| 133 | CAMKK2 | 0.44443360 |
| 134 | ERBB2 | 0.43824962 |
| 135 | MKNK1 | 0.43515258 |
| 136 | LCK | 0.43367179 |
| 137 | RPS6KA5 | 0.42318920 |
| 138 | TAOK1 | 0.41969406 |
| 139 | CAMK1G | 0.41815293 |
| 140 | TNK2 | 0.40174995 |
| 141 | PTK2B | 0.36495081 |
| 142 | FYN | 0.35647599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.10883133 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.17658681 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.82456919 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.77649834 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76597385 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 1.74390658 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.74279845 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.66395743 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.56179729 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.53256081 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.47644441 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.46508322 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.46286209 |
| 14 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.45596861 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.44214302 |
| 16 | Apoptosis_Homo sapiens_hsa04210 | 1.42023092 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.40824160 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40605034 |
| 19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.40112711 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.37820625 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.34200455 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.33915068 |
| 23 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.29664427 |
| 24 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27434254 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.26679475 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.26370591 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.25358408 |
| 28 | Adherens junction_Homo sapiens_hsa04520 | 1.25035735 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.24858210 |
| 30 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.24198665 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.23941978 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.21772307 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.20050274 |
| 34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.19713993 |
| 35 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.17297679 |
| 36 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.17037552 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.16912040 |
| 38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.14647346 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.10665440 |
| 40 | Measles_Homo sapiens_hsa05162 | 1.10258293 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10009037 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09899471 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.08586421 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06974538 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06622184 |
| 46 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06071098 |
| 47 | Tuberculosis_Homo sapiens_hsa05152 | 1.05902778 |
| 48 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.04122754 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.02378765 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00446226 |
| 51 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.98991294 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.98550628 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.98512630 |
| 54 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.97767971 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 0.95418055 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93752174 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92188864 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91762440 |
| 59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.91697986 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.90864014 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90509406 |
| 62 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.90449959 |
| 63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90218931 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.89265156 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88960800 |
| 66 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.88203413 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.85985398 |
| 68 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.85976528 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85812062 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.85511098 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85158072 |
| 72 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.84358647 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84235049 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83597648 |
| 75 | Retinol metabolism_Homo sapiens_hsa00830 | 0.83001083 |
| 76 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81967715 |
| 77 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81734729 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81149516 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.80931666 |
| 80 | Focal adhesion_Homo sapiens_hsa04510 | 0.80495894 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.80445682 |
| 82 | Hepatitis B_Homo sapiens_hsa05161 | 0.79848631 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78073256 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77811648 |
| 85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77768277 |
| 86 | Shigellosis_Homo sapiens_hsa05131 | 0.76174363 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74562865 |
| 88 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73959148 |
| 89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73932369 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.73235749 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72559538 |
| 92 | Prostate cancer_Homo sapiens_hsa05215 | 0.72547778 |
| 93 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72133350 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70868086 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70685019 |
| 96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.70101504 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70071475 |
| 98 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.68959371 |
| 99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68522312 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.67254745 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67016694 |
| 102 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.65989560 |
| 103 | Salmonella infection_Homo sapiens_hsa05132 | 0.65896262 |
| 104 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65499405 |
| 105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64981078 |
| 106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64679250 |
| 107 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64584762 |
| 108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64414670 |
| 109 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64134492 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.63661035 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63355922 |
| 112 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63083235 |
| 113 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.62934094 |
| 114 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62677342 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.62437055 |
| 116 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.61228569 |
| 117 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60986314 |
| 118 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59687688 |
| 119 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59464467 |
| 120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58439105 |
| 121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58437731 |
| 122 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.57610767 |
| 123 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56990808 |
| 124 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56763888 |
| 125 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54863912 |
| 126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53345236 |
| 127 | Glioma_Homo sapiens_hsa05214 | 0.51652833 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51415642 |
| 129 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49572416 |
| 130 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49282623 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49227368 |
| 132 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48189912 |
| 133 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47442241 |
| 134 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44780736 |
| 135 | Endocytosis_Homo sapiens_hsa04144 | 0.43556741 |
| 136 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39857105 |
| 137 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39740987 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38699109 |

